TI, W., JE, W., CM, L., JW, L., TH, K., BC, S., . . . YM, P. (2020). Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma. Dove Medical Press.
Chicago Style (17th ed.) CitationTI, Wi, Won JE, Lee CM, Lee JW, Kang TH, Shin BC, Han HD, and Park YM. Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma. Dove Medical Press, 2020.
MLA (8th ed.) CitationTI, Wi, et al. Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma. Dove Medical Press, 2020.
Warning: These citations may not always be 100% accurate.